RAPHAS CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 13,360 KRW | -1.18% |
|
+0.30% | -30.74% |
| 15/02 | Raphas Co., Ltd. announces an Equity Buyback for KRW 3,000 million worth of its shares. | CI |
| 15/02 | Raphas Co., Ltd. authorizes a Buyback Plan. | CI |
| Sales 2022 | 23.64B 17.19M 1.43B | Sales 2023 | 27.94B 20.31M 1.69B | Capitalization | 165B 120M 10.02B |
|---|---|---|---|---|---|
| Net income 2022 | -8.51B -6.19M -516M | Net income 2023 | -8.8B -6.4M -533M | EV / Sales 2022 | 5.27 x |
| Net cash position 2022 | 9.8B 7.12M 593M | Net Debt 2023 | 6.89B 5.01M 418M | EV / Sales 2023 | 6.17 x |
| P/E ratio 2022 |
-16.1
x | P/E ratio 2023 |
-18.9
x | Employees | 92 |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 70.52% |
More Fundamentals
* Assessed data
More news
| 1 day | -1.18% | ||
| 1 week | +0.30% | ||
| Current month | -21.92% | ||
| 1 month | -22.01% | ||
| 3 months | -24.05% | ||
| 6 months | -31.03% | ||
| Current year | -30.74% |
1 week
13 120.00
13 890.00
1 month
13 100.0017 280.00
Current year
13 100.0020 150.00
1 year
13 100.0031 450.00
3 years
13 100.0080 500.00
5 years
7 500.0080 500.00
10 years
7 500.0080 500.00
| Managers | Title | Age | Since |
|---|---|---|---|
Do-Hyeon Jeong
CEO | Chief Executive Officer | 55 | 01/09/01 |
Yong-Hui Lee
DFI | Director of Finance/CFO | 48 | 15/14/15 |
Sook-Hui Na
CTO | Chief Tech/Sci/R&D Officer | 52 | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Do-Hyeon Jeong
CEO | Chief Executive Officer | 55 | 01/09/01 |
Yong-Hui Lee
DFI | Director of Finance/CFO | 48 | 15/14/15 |
Joo-Yeob Shin
BRD | Director/Board Member | 48 | 01/15/01 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/24/26 | 13,360 | -1.18% | 11,154 |
| 25/24/25 | 13,520 | -0.52% | 6,006 |
| 24/24/24 | 13,590 | +1.12% | 18,977 |
| 23/24/23 | 13,440 | -1.03% | 9,416 |
| 22/24/22 | 13,580 | +1.95% | 15,236 |
End-of-day quote Korea S.E., April 26, 2024
More quotes
Raphas Co., Ltd. is a Korea-based company mainly engaged in the research, development manufacturing and distribution of microarray patches. The Company develops cosmetics based on microstructure technology. In addition, the Company sells cosmetics, pharmaceutical patches, health functional foods under the brand name of Acropass.
Sector
Personal Products
Calendar
10/05/2024
- Q1 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -30.74% | 83.22M | |
| +10.09% | 18.86B | |
| 0.00% | 17.37B | |
| -1.32% | 10.65B | |
| -7.73% | 10.26B | |
| +3.86% | 6.72B | |
| +9.76% | 5.94B | |
| -0.06% | 4.55B | |
| -16.98% | 3.83B | |
| -6.25% | 3.48B |
- Stock Market
- Equities
- A214260 Stock
